MX2016000783A - Metodos para preparar rotavirus inactivado. - Google Patents
Metodos para preparar rotavirus inactivado.Info
- Publication number
- MX2016000783A MX2016000783A MX2016000783A MX2016000783A MX2016000783A MX 2016000783 A MX2016000783 A MX 2016000783A MX 2016000783 A MX2016000783 A MX 2016000783A MX 2016000783 A MX2016000783 A MX 2016000783A MX 2016000783 A MX2016000783 A MX 2016000783A
- Authority
- MX
- Mexico
- Prior art keywords
- rotavirus
- inactivated
- bovine
- methods
- temperature
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12361—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
En la presente se describen métodos para producir rotavirus inactivado directamente a partir de sobrenadantes de cultivo celular que contienen rotavirus activos o infecciosos (por ejemplo, rotavirus de origen bovino), sin un aislamiento o purificación previos de dicho rotavirus a partir de los sobrenadantes de cultivo celular. En algunas modalidades, el rotavirus inactivado (por ejemplo, rotavirus de origen bovino) se produce al calentar un volumen de sobrenadante de cultivo a al menos una temperatura a la cual el rotavirus se inactiva. En algunas modalidades, el rotavirus (por ejemplo, rotavirus de origen bovino) se inactiva una vez que el volumen entero se calienta a al menos una temperatura a la cual el rotavirus se inactiva. En algunas modalidades, la temperatura del sobrenadante de cultivo celular se mantiene durante una cantidad de tiempo adecuada, la cual puede determinarse usando cualquiera de las pruebas descritas en la presente. El rotavirus inactivado (por ejemplo, rotavirus de origen bovino) puede posteriormente aislarse del sobrenadante de cultivo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361856294P | 2013-07-19 | 2013-07-19 | |
| PCT/US2014/047164 WO2015010002A1 (en) | 2013-07-19 | 2014-07-18 | Methods for preparing inactivated rotavirus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016000783A true MX2016000783A (es) | 2016-04-27 |
| MX366915B MX366915B (es) | 2019-07-30 |
Family
ID=51293170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000783A MX366915B (es) | 2013-07-19 | 2014-07-18 | Métodos para preparar rotavirus inactivado. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10030232B2 (es) |
| EP (1) | EP3021867B1 (es) |
| JP (1) | JP6089150B2 (es) |
| CN (1) | CN105451764B (es) |
| AU (1) | AU2014290523B2 (es) |
| BR (1) | BR112015032773A8 (es) |
| CA (1) | CA2913662C (es) |
| EA (1) | EA038610B1 (es) |
| ES (1) | ES2732301T3 (es) |
| HK (1) | HK1217174A1 (es) |
| MX (1) | MX366915B (es) |
| NZ (1) | NZ714544A (es) |
| PL (1) | PL3021867T3 (es) |
| PT (1) | PT3021867T (es) |
| WO (1) | WO2015010002A1 (es) |
| ZA (1) | ZA201508666B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109355263A (zh) * | 2018-12-11 | 2019-02-19 | 中国医学科学院医学生物学研究所 | 利用生物反应器生产轮状病毒的方法 |
| CN114410592B (zh) * | 2021-12-30 | 2024-05-24 | 苏州百源基因技术有限公司 | 一种轮状病毒培养基及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101051986B1 (ko) * | 2006-09-28 | 2011-07-26 | 중앙대학교 산학협력단 | 인간로타바이러스 및 이를 이용한 백신 조성물 |
| WO2009032913A2 (en) * | 2007-09-04 | 2009-03-12 | The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services | Thermal inactivation of rotavirus |
| EP2661277A2 (en) * | 2011-01-05 | 2013-11-13 | Bharat Biotech International Limited | A combination heptavalent vaccine |
-
2014
- 2014-07-18 JP JP2016527120A patent/JP6089150B2/ja active Active
- 2014-07-18 PL PL14748051T patent/PL3021867T3/pl unknown
- 2014-07-18 MX MX2016000783A patent/MX366915B/es active IP Right Grant
- 2014-07-18 PT PT14748051T patent/PT3021867T/pt unknown
- 2014-07-18 NZ NZ714544A patent/NZ714544A/en unknown
- 2014-07-18 EA EA201592175A patent/EA038610B1/ru unknown
- 2014-07-18 WO PCT/US2014/047164 patent/WO2015010002A1/en active Application Filing
- 2014-07-18 CN CN201480039910.9A patent/CN105451764B/zh active Active
- 2014-07-18 BR BR112015032773A patent/BR112015032773A8/pt not_active Application Discontinuation
- 2014-07-18 EP EP14748051.1A patent/EP3021867B1/en active Active
- 2014-07-18 US US14/898,506 patent/US10030232B2/en active Active
- 2014-07-18 ES ES14748051T patent/ES2732301T3/es active Active
- 2014-07-18 CA CA2913662A patent/CA2913662C/en active Active
- 2014-07-18 AU AU2014290523A patent/AU2014290523B2/en active Active
-
2015
- 2015-11-25 ZA ZA2015/08666A patent/ZA201508666B/en unknown
-
2016
- 2016-05-06 HK HK16105185.6A patent/HK1217174A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201592175A1 (ru) | 2016-08-31 |
| WO2015010002A1 (en) | 2015-01-22 |
| HK1217174A1 (zh) | 2016-12-30 |
| JP6089150B2 (ja) | 2017-03-01 |
| BR112015032773A8 (pt) | 2018-01-23 |
| EP3021867A1 (en) | 2016-05-25 |
| US20160145583A1 (en) | 2016-05-26 |
| PT3021867T (pt) | 2019-06-24 |
| CN105451764A (zh) | 2016-03-30 |
| MX366915B (es) | 2019-07-30 |
| EA038610B1 (ru) | 2021-09-22 |
| AU2014290523B2 (en) | 2016-12-08 |
| EP3021867B1 (en) | 2019-04-17 |
| CA2913662C (en) | 2021-05-04 |
| BR112015032773A2 (pt) | 2017-07-25 |
| NZ714544A (en) | 2016-11-25 |
| JP2016525120A (ja) | 2016-08-22 |
| AU2014290523A1 (en) | 2015-12-24 |
| CN105451764B (zh) | 2021-04-02 |
| ES2732301T3 (es) | 2019-11-21 |
| US10030232B2 (en) | 2018-07-24 |
| PL3021867T3 (pl) | 2019-09-30 |
| ZA201508666B (en) | 2017-07-26 |
| CA2913662A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501376A1 (en) | Processing biomass and energy | |
| PH12017501445A1 (en) | Methods for producing virus for vaccine production | |
| EP3268308B8 (en) | Method and system for the manufacture of methane, heat and electricity by hydrogasification of biomass | |
| EA201300915A1 (ru) | Новый европейский штамм prrsv | |
| MX2021014663A (es) | Il-23a y tnf-alfa orientados y compuesto y sus usos. | |
| MX368142B (es) | Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab. | |
| MX2018014043A (es) | Composiciones de cultivo celular con antioxidantes y metodos para la produccion de polipeptidos. | |
| MX2015011781A (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
| MX2015012168A (es) | Expansión de celulas madre adultas in vitro. | |
| NZ703973A (en) | Complex chromosome engineering for production of human antibodies in transgenic animals | |
| IN2014MU00455A (es) | ||
| GB201017519D0 (en) | Vaccines | |
| MX2020001357A (es) | Produccion microbiana de aminas grasas. | |
| MX2016000141A (es) | El uso de piridonacarboxamidas seleccionadas o sales de las mismas como sustancias activas contra el estres abiotico de las plantas. | |
| IN2013MU03417A (es) | ||
| IN2014DN09097A (es) | ||
| NZ714544A (en) | Methods for preparing inactivated rotavirus | |
| MX2018010375A (es) | Nueva glucoquinasa dependiente de polifosfato y metodo para preparar glucosa 6-fosfato usando la misma. | |
| PH12015501132A1 (en) | Improved methods for inducing apomixis in plants | |
| AR090964A1 (es) | Proceso para la elaboracion de undecapeptidos ciclicos | |
| PL406487A1 (pl) | Sposób produkcji kwasu bursztynowego oraz pożywka bakteryjna do produkcji kwasu bursztynowego | |
| IN2013MU01966A (es) | ||
| MX2016001100A (es) | Proceso mejorado para preparar la forma cristalina iv del posaconazol. | |
| IN2013MU02771A (es) | ||
| UA88864U (uk) | Спосіб підготовки глибоко-пом'якшеної води |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status |
Owner name: NOXELL CORPORATION |
|
| FG | Grant or registration |